Lipoprotein(a): Implications for clinical practice Robert C. BlockThomas A. Pearson Invited Commentary Pages: 327 - 329
New insights in the treatment of dyslipidemia: A focus on cardiovascular event reduction and the antiatherosclerotic effects of atorvastatin Peter P. Toth OriginalPaper Pages: 335 - 343
Hepatic high-density lipoprotein receptors: Roles in lipoprotein metabolism and potential for therapeutic modulation Bernardo L. Trigatti OriginalPaper Pages: 344 - 350
Evidence-based management of peripheral vascular disease Nicolas W. ShammasEric J. Dippel OriginalPaper Pages: 358 - 363
The role of statins in the prevention of ischemic stroke Bo ZiedénAnders G. Olsson OriginalPaper Pages: 364 - 368
Impact of thiazolidinedione therapy on atherogenesis Jeroen P. H. van WijkTon J. Rabelink OriginalPaper Pages: 369 - 374
Extending the cardiovascular benefits of omega-3 fatty acids William S. Harris OriginalPaper Pages: 375 - 380
Metabolic syndrome: Demographic features, etiology, and clinical management Kathleen L. Wyne OriginalPaper Pages: 381 - 388
Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein Marlys L. Koschinsky OriginalPaper Pages: 389 - 395
Pleiotropic effects of fibrates Giulia Chinetti-GbaguidiJean Charles FruchartBart Staels OriginalPaper Pages: 396 - 401